166 related articles for article (PubMed ID: 28468037)
41. CXCL14-CXCR4 and CXCL12-CXCR4 Axes May Play Important Roles in the Unique Invasion Process of Endometrioid Carcinoma With MELF-Pattern Myoinvasion.
Kojiro-Sanada S; Yasuda K; Nishio S; Ogasawara S; Akiba J; Ushijima K; Yano H
Int J Gynecol Pathol; 2017 Nov; 36(6):530-539. PubMed ID: 28277316
[TBL] [Abstract][Full Text] [Related]
42. Disseminated tumor cells are not associated with established risk factors, L1CAM immunoreactivity and outcome in endometrial carcinoma.
Kommoss S; Hartkopf AD; Krämer B; Bunz AK; Grevenkamp F; Kommoss F; Pasternak J; Arbabi SM; Wallwiener M; Staebler A; Lax SF; Brucker SY; Taran FA
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2183-2188. PubMed ID: 28710714
[TBL] [Abstract][Full Text] [Related]
43. Diffusely infiltrative endometrial adenocarcinoma: an adenoma malignum pattern of myoinvasion.
Longacre TA; Hendrickson MR
Am J Surg Pathol; 1999 Jan; 23(1):69-78. PubMed ID: 9888705
[TBL] [Abstract][Full Text] [Related]
44. Expression of cell cycle regulatory proteins in endometrial adenocarcinoma: variations in conventional tumor areas and in microcystic, elongated and fragmented glands.
Stewart CJ; Crook ML; Leung YC; Platten M
Mod Pathol; 2009 May; 22(5):725-33. PubMed ID: 19270644
[TBL] [Abstract][Full Text] [Related]
45. Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma.
Ismiil ND; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Thomas G; Ackerman I; Covens A; Khalifa MA
Int J Gynecol Pathol; 2007 Jul; 26(3):278-83. PubMed ID: 17581412
[TBL] [Abstract][Full Text] [Related]
46. Galectin-3 expression in uterine endometrioid adenocarcinoma: comparison of staining in conventional tumor glands and in areas of MELF pattern myometrial invasion.
Stewart CJ; Crook ML
Int J Gynecol Pathol; 2010 Nov; 29(6):555-61. PubMed ID: 20881856
[TBL] [Abstract][Full Text] [Related]
47. POLE mutation combined with microcystic, elongated and fragmented (MELF) pattern invasion in endometrial carcinomas might be associated with poor survival in Chinese women.
He D; Wang H; Dong Y; Zhang Y; Zhao J; Lv C; Zheng X; Li D; Li T
Gynecol Oncol; 2020 Oct; 159(1):36-42. PubMed ID: 32800323
[TBL] [Abstract][Full Text] [Related]
48. Patterns of Myometrial Invasion in Endometrial Adenocarcinoma with Emphasizing on Microcystic, Elongated and Fragmented (MELF) Glands Pattern: A Narrative Review of the Literature.
Mateva S; Nikolova M; Yordanov A
Diagnostics (Basel); 2021 Sep; 11(9):. PubMed ID: 34574048
[TBL] [Abstract][Full Text] [Related]
49. A suggested modification to FIGO stage I endometrial cancer.
Aristizabal P; Graesslin O; Barranger E; Clavel-Chapelon F; Haddad B; Luton D; Darai E; Rouzier R; Koskas M
Gynecol Oncol; 2014 May; 133(2):192-6. PubMed ID: 24631453
[TBL] [Abstract][Full Text] [Related]
50. Angiogenesis, p53, and bcl-2 expression as prognostic indicators in endometrial cancer: comparison with traditional clinicopathologic variables.
Erdem O; Erdem M; Dursun A; Akyol G; Erdem A
Int J Gynecol Pathol; 2003 Jul; 22(3):254-60. PubMed ID: 12819392
[TBL] [Abstract][Full Text] [Related]
51. Lymphatic vessel involvement is predictive for lymph node metastasis and an important prognostic factor in endometrial cancer.
Wakayama A; Kudaka W; Matsumoto H; Aoyama H; Ooyama T; Taira Y; Arakaki Y; Shimoji Y; Nakasone T; Nishihira K; Kaneshima I; Tamaki T; Yoshimi N; Aoki Y
Int J Clin Oncol; 2018 Jun; 23(3):532-538. PubMed ID: 29275449
[TBL] [Abstract][Full Text] [Related]
52. Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion.
Ismiil N; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Ackerman I; Thomas G; Covens A; Khalifa MA
Ann Diagn Pathol; 2007 Aug; 11(4):252-7. PubMed ID: 17630108
[TBL] [Abstract][Full Text] [Related]
53. Endometrial adenocarcinoma associated with subtle lymph-vascular space invasion and lymph node metastasis: a histologic pattern mimicking intravascular and sinusoidal histiocytes.
McKenney JK; Kong CS; Longacre TA
Int J Gynecol Pathol; 2005 Jan; 24(1):73-8. PubMed ID: 15626920
[TBL] [Abstract][Full Text] [Related]
54. Endocervical Adenocarcinoma Showing Microcystic, Elongated, and Fragmented (MELF) Pattern of Stromal Invasion: A Single-Institutional Analysis of 10 Cases with Comprehensive Clinicopathological Analyses and Ki-67 Immunostaining.
Bae H; Kim HS
Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38002025
[TBL] [Abstract][Full Text] [Related]
55. Clinicopathological significance and prognostic value of myoinvasive patterns in endometrial endometrioid carcinoma.
Amălinei C; Aignătoaei AM; Balan RA; Giuşcă SE; Lozneanu L; Avădănei ER; Căruntu ID
Rom J Morphol Embryol; 2018; 59(1):13-22. PubMed ID: 29940607
[TBL] [Abstract][Full Text] [Related]
56. Endometrial carcinomas with dyshesive, eosinophilic, and vacuolated (histiocyte-like) tumor cells: a reactive-like phenotype associated with aggressive behavior.
Travaglino A; Arciuolo D; Raffone A; Santoro A; Piermattei A; Navarra E; Minucci A; Mascolo M; Scaglione G; D'alessandris N; Valente M; Inzani F; Mollo A; Insabato L; Zannoni GF
Virchows Arch; 2023 Mar; 482(3):635-640. PubMed ID: 36205778
[TBL] [Abstract][Full Text] [Related]
57. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
[TBL] [Abstract][Full Text] [Related]
58. Nodal immune reactivity in FIGO (International Federation of Gyn-Ob) Stage I endometrial carcinoma: relationship with myometrial invasion.
Garzetti GG; Ciavattini A; Goteri G; Romanini C
Acta Obstet Gynecol Scand; 1995 Oct; 74(9):723-8. PubMed ID: 7572108
[TBL] [Abstract][Full Text] [Related]
59. Patterns of myoinvasion in endometrial adenocarcinoma: recognition and implications.
Cole AJ; Quick CM
Adv Anat Pathol; 2013 May; 20(3):141-7. PubMed ID: 23574770
[TBL] [Abstract][Full Text] [Related]
60. Detection of lymphovascular invasion by D2-40 (podoplanin) immunoexpression in endometrial cancer.
Weber SK; Sauerwald A; Pölcher M; Braun M; Debald M; Serce NB; Kuhn W; Brunagel-Walgenbach G; Rudlowski C
Int J Gynecol Cancer; 2012 Oct; 22(8):1442-8. PubMed ID: 22964524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
